Matrix-assisted laser desorption/ionization imaging mass spectrometry: A promising technique for reproductive research

Biology of Reproduction

Volumn 86, Issue 3, 2012, Pages

  Lagarrigue, Mélanie ^b   Lavigne, Régis ^b   Guével, Blandine ^b   Com, Emmanuelle ^b   Chaurand, Pierre ^b   Pineau, Charles ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Biomarkers; Cancer; Epididymis; Imaging; MALDI; Mass spectrometry; Prostate; Proteomics; Testis

Indexed keywords

ALPHA DEFENSIN; BIOLOGICAL MARKER; CA 125 ANTIGEN; CALCYCLIN; CALGIZZARIN; CYSTEINE RICH INTESTINAL PROTEIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; HISTONE H2A; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MUCIN 9; PARAFFIN; PREALBUMIN; PROSTATE SPECIFIC ANTIGEN; PROTEASOME ACTIVATOR COMPLEX PA 28; SPERMINE; THYMOSIN BETA4; UBIQUITIN; UNCLASSIFIED DRUG; UVOMORULIN; TUMOR MARKER;

BREAST CANCER; CANCER GRADING; CANCER STAGING; EMBRYO DEVELOPMENT; EPIDIDYMIS; FROZEN SECTION; GAMETOGENESIS; GENE EXPRESSION PROFILING; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NIDATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARY CANCER; OVARY CARCINOMA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; REPRODUCTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SPERMATOGENESIS; ANIMAL; MASS SPECTROMETRY; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGY; REVIEW;

ANIMALS; BIOMEDICAL RESEARCH; EMBRYONIC DEVELOPMENT; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; REPRODUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84860625090     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.094896     Document Type: Short Survey

References (99)

1. Ko MS. Expression profiling of the mouse early embryo: reflections and perspectives. Dev Dyn 2006; 235:2437-2448.
2. Rodriguez-Zas SL, Schellander K, Lewin HA. Biological interpretations of transcriptomic profiles in mammalian oocytes and embryos. Reproduction 2008; 135:129-139.
3. Wrobel G, Primig M. Mammalian male germ cells are fertile ground for expression profiling of sexual reproduction. Reproduction 2005; 129:1-7.
4. Calvel P, Rolland AD, Jegou B, Pineau C. Testicular postgenomics: targeting the regulation of spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010; 365:1481-1500.
5. Rolland AD, Jegou B, Pineau C. Testicular development and spermatogenesis: harvesting the postgenomics bounty. Adv Exp Med Biol 2008; 636:16-41.
6. Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 1997; 69:4751-4760.
7. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001; 7:493-496.
8. Chaurand P, Schwartz SA, Caprioli RM. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 2002; 6:676-681.
9. Chaurand P, Stoeckli M, Caprioli RM. Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry. Anal Chem 1999; 71:5263-5270.
10. McDonnell LA, Corthals GL, Willems SM, van Remoortere A, van Zeijl RJ, Deelder AM. Peptide and protein imaging mass spectrometry in cancer research. J Proteomics 2010; 73:1921-1944.
11. Seeley EH, Caprioli RM. MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol 2011; 29:136-143.
12. Hays JL, Kim G, Giuroiu I, Kohn EC. Proteomics and ovarian cancer: integrating proteomics information into clinical care. J Proteomics 2010; 73:1864-1872.
13. Campbell LL, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 2007; 6:2332-2338.
14. Limon A, Reyes-Ruiz JM, Eusebi F, Miledi R. Properties of GluR3 receptors tagged with GFP at the amino or carboxyl terminus. Proc Natl Acad Sci U S A 2007; 104:15526-15530.
15. Farias-Eisner R, Reddy ST. Biomarkers for early detection of ovarian cancer. U.S. patent 7 670 792; 2010.
16. Macaleese L, Stauber J, Heeren RM. Perspectives for imaging mass spectrometry in the proteomics landscape. Proteomics 2009; 9:819-834.
17. Chaurand P, Norris JL, Cornett DS, Mobley JA, Caprioli RM. New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J Proteome Res 2006; 5:2889-2900.
18. Lemaire R, Wisztorski M, Desmons A, Tabet JC, Day R, Salzet M, Fournier I. MALDI-MS direct tissue analysis of proteins: improving signal sensitivity using organic treatments. Anal Chem 2006; 78:7145-7153.
19. Seeley EH, Oppenheimer SR, Mi D, Chaurand P, Caprioli RM. Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sections. J Am Soc Mass Spectrom 2008; 19:1069-1077.
20. Lagarrigue M, Becker M, Lavigne R, Deininger SO, Walch A, Aubry F, Suckau D, Pineau C. Revisiting rat spermatogenesis with MALDI imaging at 20 lm resolution. Mol Cell Proteomics 2011; 10:M110.005991.
21. Aerni HR, Cornett DS, Caprioli RM. Automated acoustic matrix deposition for MALDI sample preparation. Anal Chem 2006; 78:827-834.
22. Cornett DS, Mobley JA, Dias EC, Andersson M, Arteaga CL, Sanders ME, Caprioli RM. A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics 2006; 5:1975-1983.
23. Shimma S, Furuta M, Ichimura K, Yoshida Y, Setou M. Direct MS/MS analysis in mammalian tissue sections using MALDI-QIT-TOFMS and chemical inkjet technology. Surf Interface Anal 2006; 38:1712-1714.
24. Djidja MC, Francese S, Loadman PM, Sutton CW, Scriven P, Claude E, Snel MF, Franck J, Salzet M, Clench MR. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections. Proteomics 2009; 9:2750-2763.
25. Groseclose MR, Massion PP, Chaurand P, Caprioli RM. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008; 8:3715-3724.
26. Lemaire R, Desmons A, Tabet JC, Day R, Salzet M, Fournier I. Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 2007; 6:1295-1305.
27. Stauber J, Lemaire R, Franck J, Bonnel D, Croix D, Day R, Wisztorski M, Fournier I, Salzet M. MALDI imaging of formalin-fixed paraffinembedded tissues: application to model animals of Parkinson disease for biomarker hunting. J Proteome Res 2008; 7:969-978.
28. Aoki T, Toyama A, Shimada T, Sugita T, Aoki C, Umino Y, Suzuki A, Aoki D, Daigo Y, Nakamura Y, Sato TA. A novel method for analyzing formalin-fixed paraffin embedded (FFPE) tissue sections by mass spectrometry imaging. Proc Jpn Acad Ser B 2007; 83:205-214.
29. Gustafsson JO, Oehler MK, McColl SR, Hoffmann P. Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. J Proteome Res 2010; 9:4315-4328.
30. Mangé A, Chaurand P, Perrochia H, Roger P, Caprioli RM, Solassol J. Liquid chromatography-tandem and MALDI imaging mass spectrometry analyses of RCL2/CS100-fixed, paraffin-embedded tissues: proteomics evaluation of an alternate fixative for biomarker discovery. J Proteome Res 2009; 8:5619-5628.
31. Bharwani N, Reznek RH, Rockall AG. Ovarian cancer management: the role of imaging and diagnostic challenges. Eur J Radiol 2011; 78:41-51.
32. Lutz AM, Willmann JK, Drescher CW, Ray P, Cochran FV, Urban N, Gambhir SS. Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology 2011; 259:329-345.
33. Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, Gajewski W, Kurman R, Bast RC Jr, Skates SJ. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 2009; 112:40-46.
34. Gustafsson JO, Oehler MK, Ruszkiewicz A, McColl SR, Hoffmann P. MALDI imaging mass spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis. Int J Mol Sci 2011; 12:773-794.
35. Lemaire R, Menguellet SA, Stauber J, Marchaudon V, Lucot JP, Collinet P, Farine MO, Vinatier D, Day R, Ducoroy P, Salzet M, Fournier I. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res 2007; 6:4127-4134.
36. Lemaire R, Stauber J, Wisztorski M, Van Camp C, Desmons A, Deschamps M, Proess G, Rudlof I, Woods AS, Day R, Salzet M, Fournier I. Tag-mass: specific molecular imaging of transcriptome and proteome by mass spectrometry based on photocleavable tag. J Proteome Res 2007; 6:2057-2067.
37. El Ayed M, Bonnel D, Longuespee R, Castelier C, Franck J, Vergara D, Desmons A, Tasiemski A, Kenani A, Vinatier D, Day R, Fournier I, et al. MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers. Med Sci Monit 2010; 16:BR233-BR245.
38. Kang S, Shim HS, Lee JS, Kim DS, Kim HY, Hong SH, Kim PS, Yoon JH, Cho NH. Molecular proteomics imaging of tumor interfaces by mass spectrometry. J Proteome Res 2010; 9:1157-1164.
39. Liu Y, Chen Y, Momin A, Shaner R, Wang E, Bowen NJ, Matyunina LV, Walker LD, McDonald JF, Sullards MC, Merrill AH Jr. Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol Cancer 2010; 9:186.
40. Cheung KL. Endocrine therapy for breast cancer: an overview. Breast 2007; 16:327-343.
41. Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 2009; 14:320-368.
42. Hondermarck H, Tastet C, El Yazidi-Belkoura I, Toillon RA, Le Bourhis X. Proteomics of breast cancer: the quest for markers and therapeutic targets. J Proteome Res 2008; 7:1403-1411.
43. Com E, Hondermarck H. Functional proteomics in oncology: to understand more than to describe [in French]. Med Sci (Paris) 2007; 23(spec no 1):27-30.
44. Drake RR, Cazares LH, Jones EE, Fuller TW, Semmes OJ, Laronga C. Challenges to developing proteomic-based breast cancer diagnostics. OMICS 2011; 15:251-259.
45. Seeley EH, Caprioli RM. Molecular imaging of proteins in tissues by mass spectrometry. Proc Natl Acad Sci U S A 2008; 105:18126-18131.
46. Seeley EH, Caprioli RM. Imaging mass spectrometry: towards clinical diagnostics. Proteomics Clin Appl 2008; 2:1435-1443.
47. Amstalden van Hove ER, Blackwell TR, Klinkert I, Eijkel GB, Heeren RM, Glunde K. Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models. Cancer Res 2010; 70:9012-9021.
48. Rauser S, Marquardt C, Balluff B, Deininger SO, Albers C, Belau E, Hartmer R, Suckau D, Specht K, Ebert MP, Schmitt M, Aubele M, et al. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J Proteome Res 2010; 9:1854-1863.
49. Mackay A, Jones C, Dexter T, Silva RL, Bulmer K, Jones A, Simpson P, Harris RA, Jat PS, Neville AM, Reis LF, Lakhani SR, et al. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 2003; 22:2680-2688.
50. Wilson KS, Roberts H, Leek R, Harris AL, Geradts J. Differential gene expression patterns in HER2/neu-positive and-negative breast cancer cell lines and tissues. Am J Pathol 2002; 161:1171-1185.
51. Reyzer ML, Caldwell RL, Dugger TC, Forbes JT, Ritter CA, Guix M, Arteaga CL, Caprioli RM. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 2004; 64:9093-9100.
52. Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, et al. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res 2010; 16:681-690.
53. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007; 12:20-37.
54. Chiriva-Internati M, Yu Y, Mirandola L, D'Cunha N, Hardwicke F, Cannon MJ, Cobos E, Kast WM. Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. Prostate 2012; 72:12-23.
55. Chaurand P, DaGue BB, Ma S, Kasper S, Caprioli RM. Strain-based sequence variations and structure analysis of murine prostate specific spermine binding protein using mass spectrometry. Biochemistry 2001; 40:9725-9733.
56. Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 2001; 61:2239-2249.
57. Schwamborn K, Krieg RC, Reska M, Jakse G, Knuechel R, Wellmann A. Identifying prostate carcinoma by MALDI-Imaging. Int J Mol Med 2007; 20:155-159.
58. Chaurand P, Rahman MA, Hunt T, Mobley JA, Gu G, Latham JC, Caprioli RM, Kasper S. Monitoring mouse prostate development by profiling and imaging mass spectrometry. Mol Cell Proteomics 2008; 7:411-423.
59. Cazares LH, Troyer D, Mendrinos S, Lance RA, Nyalwidhe JO, Beydoun HA, Clements MA, Drake RR, Semmes OJ. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res 2009; 15:5541-5551.
60. Burnum KE, Tranguch S, Mi D, Daikoku T, Dey SK, Caprioli RM. Imaging mass spectrometry reveals unique protein profiles during embryo implantation. Endocrinology 2008; 149:3274-3278.
61. Burnum KE, Cornett DS, Puolitaival SM, Milne SB, Myers DS, Tranguch S, Brown HA, Dey SK, Caprioli RM. Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J Lipid Res 2009; 50:2290-2298.
62. Cornwall G, Lareyre JJ, Matusik R, Hinton B, Orgebin-Crist MC. Gene expression and epididymal function in the epididymis. In: Robaire B, Hinton BT (eds.), The Epididymis: From Molecules to Clinical Practice. New York: Kluwer Academic/Plenum Press; 2002; 169-199.
63. Dacheux JL, Druart X, Fouchecourt S, Syntin P, Gatti JL, Okamura N, Dacheux F. Role of epididymal secretory proteins in sperm maturation with particular reference to the boar. J Reprod Fertil Suppl 1998; 53:99-107.
64. Orgebin-Crist MC. Androgens and epididymal function. In: Bhasin S, Gabelnick H, Spieler G, Swerdloff R, Wand C (eds.), Pharmacology, Biology, and Clinical Application of Androgens. New York: Wiley-Liss Inc.; 1996; 27-38.
65. Chaurand P, Caprioli RM. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 2002; 23:3125-3135.
66. Rankin TL, Tsuruta KJ, Holland MK, Griswold MD, Orgebin-Crist MC. Isolation, immunolocalization, and sperm-association of three proteins of 18, 25, and 29 kilodaltons secreted by the mouse epididymis. Biol Reprod 1992; 46:747-766.
67. Chaurand P, Fouchecourt S, DaGue BB, Xu BJ, Reyzer ML, Orgebin-Crist MC, Caprioli RM. Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry. Proteomics 2003; 3:2221-2239.
68. Cornett DS, Reyzer ML, Chaurand P, Caprioli RM. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods 2007; 4:828-833.
69. Gnessi L, Fabbri A, Spera G. Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment. Endocr Rev 1997; 18:541-609.
70. Jégou B, Pineau C, Dupaix A. Paracrine control of testis function. In: Wang C (ed.), Male Reproductive Function, Endocrine Update Series. Berlin: Kluwer Academic; 1999; 41-64.
71. Jegou B. The Sertoli-germ cell communication network in mammals. Int Rev Cytol 1993; 147:25-96.
72. Jégou B, Sharpe RM. Paracrine mechanisms in testicular control. In: de Kretser DM (ed.), Molecular Biology of the Male Reproduction. New York: Academic Press; 1993; 271-310.
73. Sharpe RM. Regulation of spermatogenesis. In: Knobil E, Neill JD (eds.), The Physiology of Reproduction, 2nd ed. New York: Raven Press; 1994; 1363-1436.
74. Zhao GQ, Garbers DL. Male germ cell specification and differentiation. Dev Cell 2002; 2:537-547.
75. Goto-Inoue N, Hayasaka T, Zaima N, Setou M. The specific localization of seminolipid molecular species on mouse testis during testicular maturation revealed by imaging mass spectrometry. Glycobiology 2009; 19:950-957.
76. Rodemer C, Thai TP, Brugger B, Kaercher T, Werner H, Nave KA, Wieland F, Gorgas K, Just WW. Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum Mol Genet 2003; 12:1881-1895.
77. Attar M, Kates M, Bou Khalil M, Carrier D, Wong PT, Tanphaichitr N. A Fourier-transform infrared study of the interaction between germ-cell specific sulfogalactosylglycerolipid and dimyristoylglycerophosphocholine. Chem Phys Lipids 2000; 106:101-114.
78. Bou Khalil M, Chakrabandhu K, Xu H, Weerachatyanukul W, Buhr M, Berger T, Carmona E, Vuong N, Kumarathasan P, Wong PT, Carrier D, Tanphaichitr N. Sperm capacitation induces an increase in lipid rafts having zona pellucida binding ability and containing sulfogalactosylglycerolipid. Dev Biol 2006; 290:220-235.
79. Fujimoto H, Tadano-Aritomi K, Tokumasu A, Ito K, Hikita T, Suzuki K, Ishizuka I. Requirement of seminolipid in spermatogenesis revealed by UDP-galactose: ceramide galactosyltransferase-deficient mice. J Biol Chem 2000; 275:22623-22626.
80. Chaurand P, Schriver KE, Caprioli RM. Instrument design and characterization for high resolution MALDI-MS imaging of tissue sections. J Mass Spectrom 2007; 42:476-489.
81. Puolitaival SM, Burnum KE, Cornett DS, Caprioli RM. Solvent-free matrix dry-coating for MALDI imaging of phospholipids. J Am Soc Mass Spectrom 2008; 19:882-886.
82. Chaurand P, Cornett DS, Angel PM, Caprioli RM. From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry. Mol Cell Proteomics 2011; 10:O110.004259.
83. Hankin JA, Barkley RM, Murphy RC. Sublimation as a method of matrix application for mass spectrometric imaging. J Am Soc Mass Spectrom 2007; 18:1646-1652.
84. Yang J, Caprioli RM. Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution. Anal Chem 2011; 83:5728-5734.
85. Jurchen JC, Rubakhin SS, Sweedler JV. MALDI-MS imaging of features smaller than the size of the laser beam. J Am Soc Mass Spectrom 2005; 16:1654-1659.
86. Luxembourg SL, Mize TH, McDonnell LA, Heeren RM. High-spatial resolution mass spectrometric imaging of peptide and protein distributions on a surface. Anal Chem 2004; 76:5339-5344.
87. Spengler B, Hubert M. Scanning microprobe matrix-assisted laser desorption ionization (SMALDI) mass spectrometry: instrumentation for sub-micrometer resolved LDI and MALDI surface analysis. J Am Soc Mass Spectrom 2002; 13:735-748.
88. van Remoortere A, van Zeijl RJ, van den Oever N, Franck J, Longuespee R, Wisztorski M, Salzet M, Deelder AM, Fournier I, McDonnell LA. MALDI imaging and profiling MS of higher mass proteins from tissue. J Am Soc Mass Spectrom 2010; 21:1922-1929.
89. Leinweber BD, Tsaprailis G, Monks TJ, Lau SS. Improved MALDI-TOF imaging yields increased protein signals at high molecular mass. J Am Soc Mass Spectrom 2008; 20:89-95.
90. Franck J, Longuespee R, Wisztorski M, Van Remoortere A, Van Zeijl R, Deelder A, Salzet M, McDonnell L, Fournier I. MALDI mass spectrometry imaging of proteins exceeding 30,000 daltons. Med Sci Monit 2010; 16:BR293-BR299.
91. Mainini V, Angel PM, Magni F, Caprioli RM. Detergent enhancement of on-tissue protein analysis by matrix-assisted laser desorption/ionization imaging mass spectrometry. Rapid Commun Mass Spectrom 2011; 25:199-204.
92. Groseclose MR, Andersson M, Hardesty WM, Caprioli RM. Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. J Mass Spectrom 2007; 42:254-262.
93. Debois D, Bertrand V, Quinton L, De Pauw-Gillet MC, De Pauw E. MALDI-in source decay applied to mass spectrometry imaging: a new tool for protein identification. Anal Chem 2010; 82:4036-4045.
94. Heeren RM, Smith DF, Stauber J, Kukrer-Kaletas B, MacAleese L. Imaging mass spectrometry: hype or hope? J Am Soc Mass Spectrom 2009; 20:1006-1014.
95. Bruand J, Sistla S, Meriaux C, Dorrestein PC, Gaasterland T, Ghassemian M, Wisztorski M, Fournier I, Salzet M, Macagno E, Bafna V. Automated querying and identification of novel peptides using MALDI mass spectrometric imaging. J Proteome Res 2011; 10:1915-1928.
96. Watrous JD, Alexandrov T, Dorrestein PC. The evolving field of imaging mass spectrometry and its impact on future biological research. J Mass Spectrom 2011; 46:209-222.
97. Spraggins JM, Caprioli RM. High-speed MALDI-TOF imaging mass spectrometry: rapid ion image acquisition and considerations for next generation instrumentation. J Am Soc Mass Spectrom 2011; 22:1022-1031.
98. Leblond CP, Clermont Y. Definition of stages of the cycle of the seminiferous epthelium in the rat. Ann N Y Acad Sci 1952; 55:548-573.
99. Dym M, Clermont Y. Role of spermatogonia in the repair of the seminiferous epithelium following x-irradiation of the rat testis. Am J Anat 1970; 128:265-282.